Sirtuin 2 inhibition modulates chromatin landscapes genome-wide to induce senescence in ATRX-deficient malignant glioma.
Prit Benny MalgulwarCarla DanussiSharvari DharmaiahWilliam JohnsonAnand SinghKunal RaiArvind RaoJason T HusePublished in: Neuro-oncology (2023)
Our findings indicate that SIRT2 inhibition selectively targets ATRX-deficient gliomas for senescence through global chromatin remodeling, while demonstrating more broadly a viable approach to combat complex epigenetic rewiring in cancer.